当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析 - 现金流量表

方盛制药

(603998)

  

流通市值:53.52亿  总市值:53.52亿
流通股本:4.39亿   总股本:4.39亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金796,406,749.01378,348,512.331,763,106,017.411,298,554,304.1
  收到的税费返还824,405.67584,472.476,787,408.976,420,212.1
  收到其他与经营活动有关的现金39,986,016.2915,465,268.2853,087,188.9350,567,400.85
  经营活动现金流入小计837,217,170.97394,398,253.081,822,980,615.311,355,541,917.05
  购买商品、接受劳务支付的现金164,043,152.5689,769,740.77442,060,512.05348,033,938.98
  支付给职工以及为职工支付的现金143,436,506.579,133,811.74277,721,938.18211,294,220.96
  支付的各项税费95,002,019.4249,818,813.97206,621,249.64152,743,407.62
  支付其他与经营活动有关的现金305,247,124.82153,749,787.25701,629,476.88526,483,021.68
  经营活动现金流出小计707,728,803.3372,472,153.731,628,033,176.751,238,554,589.24
  经营活动产生的现金流量净额129,488,367.6721,926,099.35194,947,438.56116,987,327.81
二、投资活动产生的现金流量:
  收回投资收到的现金247,001,788.8921,000,00098,515,561.977,073,422.65
  取得投资收益收到的现金257,825.1882,964.38339,378.95250,730.7
  处置固定资产、无形资产和其他长期资产收回的现金净额1,309,140500,96028,954,373.243,438,014.25
  处置子公司及其他营业单位收到的现金净额24,398,706.2624,563,206.2622,892,402.2120,673,766.71
  收到的其他与投资活动有关的现金47,729,00033,000,00062,800,00012,000,000
  投资活动现金流入小计320,696,460.3379,147,130.64213,501,716.3113,435,934.31
  购建固定资产、无形资产和其他长期资产支付的现金47,298,903.2817,502,125.9694,789,595.6779,457,951.56
  投资支付的现金260,000,00060,430,15077,668,532.0371,700,000
  投资活动现金流出小计307,298,903.2877,932,275.96172,458,127.7151,157,951.56
  投资活动产生的现金流量净额13,397,557.051,214,854.6841,043,588.6-37,722,017.25
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,625,0002,325,0003,930,0003,700,000
  其中:子公司吸收少数股东投资收到的现金4,625,0002,325,0003,930,000-
  取得借款收到的现金329,400,000155,000,000906,664,583.33618,464,583.33
  筹资活动现金流入小计334,025,000157,325,000910,594,583.33622,164,583.33
  偿还债务支付的现金486,750,000272,300,000883,886,215588,186,215
  分配股利、利润或偿付利息支付的现金128,446,788.1730,543,760.21136,507,131.85110,288,231.82
  其中:子公司支付给少数股东的股利、利润7,006,500-7,006,500-
  支付其他与筹资活动有关的现金43,063,982.19830,263.4112,201,281.596,155,002.26
  筹资活动现金流出小计658,260,770.36303,674,023.621,032,594,628.44704,629,449.08
  筹资活动产生的现金流量净额-324,235,770.36-146,349,023.62-122,000,045.11-82,464,865.75
四、汇率变动对现金及现金等价物的影响-0.19-0.060.670.87
五、现金及现金等价物净增加额-181,349,845.83-123,208,069.65113,990,982.72-3,199,554.32
  加:期初现金及现金等价物余额296,022,032.75296,022,033.54182,031,050.03182,031,050.03
  期末现金及现金等价物余额114,672,186.92172,813,963.89296,022,032.75178,831,495.71
补充资料:
  净利润166,494,080.22-249,848,866.44-
  资产减值准备54,625.6-20,619,446.54-
  固定资产和投资性房地产折旧29,316,359.35-55,587,619.26-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧29,316,359.35-55,587,619.26-
  无形资产摊销9,533,315.01-18,045,879.24-
  长期待摊费用摊销4,055,262-8,601,521.67-
  处置固定资产、无形资产和其他长期资产的损失-20,669,772.23--746,351.63-
  固定资产报废损失27,753.74-46,383.33-
  公允价值变动损失--21,182.07-
  财务费用6,335,566.43-13,618,975.51-
  投资损失-1,376,986.92--38,557,369.89-
  递延所得税-667,698.79-4,364,520.63-
  其中:递延所得税资产减少339,791.29-5,133,494.28-
    递延所得税负债增加-1,007,490.08--768,973.65-
  存货的减少-7,286,195.93--62,360,905.4-
  经营性应收项目的减少-31,365,812.96--54,606,588.82-
  经营性应付项目的增加-30,594,313.33--30,742,973.91-
  其他175,229.28-3,403,240.22-
  现金的期末余额114,672,186.92-296,022,032.75-
  减:现金的期初余额296,022,032.75-182,031,050.03-
  现金及现金等价物的净增加额-181,349,845.83-113,990,982.72-
公告日期2025-08-292025-04-292025-04-292024-10-29
审计意见(境内)标准无保留意见
TOP↑